Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15774 articles
Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix.
T bounce predicts favorable OS and CSS after biochemical recurrence.
»
01/27/24
Non-navigated 2D intraoperative ultrasound: An unsophisticated surgical tool to achieve high standards of care in glioma surgery.
Study supports nn-2D-IOUS's invaluable role in glioma surgery.
»
10/17/23
Circular RNA CircSLC22A23 Promotes Gastric Cancer Progression by Activating HNRNPU Expression.
Knockdown of circSLC22A23 inhibited GC cell proliferation.
»
11/08/23
Comparative Efficacy and Safety of Standard and Biweekly Trifluridine/Tipiracil Regimen in Patients With Colorectal Cancer.
Neutropenia (grade ≥3) in biweekly group significantly prolonged.
»
10/24/23
Immunotherapy Combined With Standard Therapies in Head and Neck Squamous Cell Carcinoma - A Meta-analysis.
Most frequently observed adverse events related to skin.
»
01/30/24
Immune Checkpoint Inhibitor Therapy for Patients With Non-small Cell Lung Cancer Ineligible for Platinum Doublet Chemotherapy.
Patients with PS of 0-1 had favorable outcome after initiation of ICI therapy.
»
10/05/23
Efficacy of Platinum-based Chemotherapy in Patients With Metastatic Urothelial Carcinoma With Variant Histology.
Variant urothelial carcinoma independent predictor of progression.
»
10/15/23
Pro-vegetarian dietary pattern and risk of breast cancer: a case-control study.
Diet high in plant-based foods and low in animal products beneficial for reducing BC odds.
»
11/21/23
JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors
Inhibition of JAK/STAT3 represents promising therapeutic strategy for patients with stromal-rich CRC tumors.
»
03/01/24
Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis
shRNA knock-down of p53 led to increased doxorubicin-induced senescence.
»
03/01/24
< Prev
Next >